VistaGen Therapeutics, Inc. (VSTA) Taps Key Research Institutions to Achieve Strategic Objectives

California-based VistaGen Therapeutics, a biotechnology company applying proprietary human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, has been highly effective in pro-actively partnering with important academic and government research institutions to help the company strengthen the breadth and depth of its proprietary stem cell technology platform, Human Clinical Trials in a Test Tube™.

• California Institute for Regenerative Medicine (CIRM) – CIRM funds stem cell research programs throughout California, with a focus on new therapies for chronic disease and injury. The institute’s mission is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics, and research technologies.

• Centre for Commercialization of Regenerative Medicine (CCRM) – CCRM is a Canadian non-profit organization supporting the development of technologies to accelerate the commercialization of stem cell and biomaterial based products and therapies.

• McEwen Centre for Regenerative Medicine (MCRM) – MCRM is a Toronto-based organization with a mission to be a catalyst for regenerative medicine by facilitating collaboration, supporting research, and promoting awareness of the field.

• Mount Sinai School of Medicine – Home to an array of leading research institutes, centers, and laboratories, Mount Sinai School of Medicine is working toward translating advances in basic science into innovative patient care.

• National Institutes of Health (NIH) – The largest source of funding for medical research in the world, NIH is made up of 27 institutes and centers. For over a century, NIH scientists have paved the way for important discoveries that improve health and save lives.

• National Jewish Health – Known worldwide for the treatment of patients with respiratory, cardiac, immune, and related disorders, as well as for groundbreaking medical research, National Jewish Health is currently the only facility in the world dedicated exclusively to these disorders.

• University Health Network (UHN) – Building on the strengths and reputation of each of its three hospitals, UHN brings together the talent and resources needed to achieve global impact and provide exemplary patient care, research, and education.

• Wisconsin Alumni Research Foundation (WARF) – WARF serves the University of Wisconsin-Madison scientific community by patenting the discoveries of UW-Madison researchers and licensing these technologies to leading companies in Wisconsin, the United States, and worldwide.

To view other business collaborations in place, visit

Please read full disclaimers at